These sample questions apply to all exams taken on or after October 25, 2014.
The following sample questions are similar to those on the Medical-Surgical Nursing Examination but do not represent the full range of content or levels of difficulty. The answers to the sample questions are provided after the last question. Please note: Taking these or any sample question(s) is not a requirement to sit for an actual certification examination. Completion of these or any other sample question(s) does not imply eligibility for certification or successful performance on any certification examination.
To respond to the sample questions, first enter your first and last names in the boxes below (this information will not be recorded; it is strictly for purposes of identifying your results). Then click the button corresponding to the best answer for each question. When you are finished, click the "Evaluate" button at the bottom of the page. A new browser window will open, displaying your results, which you may print, if you wish.
This practice exam is not timed, and you may take it as many times as you wish. Good luck!
1. Abboud H, Henrich WL. Clinical practice. Stage IV chronic kidney disease. N Engl J Med. 2010;362:56–65. [PubMed] [Google Scholar]
2. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69:375–82. [PubMed] [Google Scholar]
3. Ardalan MR, Nasri H. Lessons from our paleolithic primogenitors; a short look to the world diabetes day 2014 with the theme of “healthy living and diabetes” J Parathyr Dis. 2014;2:57–8. [Google Scholar]
4. Rahimi Z, Mansouri Zaveleh O, Rahimi Z, Abbasi A. AT2R -1332 G: A polymorphism and diabetic nephropathy in type 2 diabetes mellitus patients. J Renal Inj Prev. 2013;2:97–101. [PMC free article] [PubMed] [Google Scholar]
5. Einollahi B. Are acquired cystic kidney disease and autosomal dominant polycystic kidney disease risk factors for renal cell carcinoma in kidney transplant patients? J Nephropathol. 2012;1:65–8. [PMC free article] [PubMed] [Google Scholar]
6. Golshahi J, Nasri H, Gharipour M. Contrast-induced nephropathy; a literature review. J Nephropathol. 2014;3:51–6. [PMC free article] [PubMed] [Google Scholar]
7. Moradi M, Rahimi Z, Amiri S, Rahimi Z, Vessal M, Nasri H. AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy. J Nephropathol. 2015;4:69–76. [PMC free article] [PubMed] [Google Scholar]
8. Arashnia R, Roohi-Gilani K, Karimi-Sari H, Nikjoo N, Bahramifar A. Effect of pioglitazone therapy on high sensitive C-reactive protein and lipid profile in diabetic patients with renal transplantation; a randomize clinical trial. J Nephropathol. 2015;4:48–53. [PMC free article] [PubMed] [Google Scholar]
9. Nasri H, Ghorbani A. Does erythropoietin slow progression of chronic kidney disease? J Renal Inj Prev. 2013;2:81–2. [PMC free article] [PubMed] [Google Scholar]
10. Roozbeh J, Sagheb MM, Vafaie E. The association between blood pressure level and serum uric acid concentration in hemodialysis patients. J Nephropathol. 2015;4:85–90. [PMC free article] [PubMed] [Google Scholar]
11. Tamadon MR, Zahmatkesh M. World kidney day 2015. J Parathyr Dis. 2015;3:34–6. [Google Scholar]
12. Kari J. Epidemiology of chronic kidney disease in children. J Nephropathol. 2012;1:162–3. [PMC free article] [PubMed] [Google Scholar]
13. Tamadon MR, Ardalan MR, Nasri H. World Kidney Day 2013; acute renal injury; a global health warning. J Parathyr Dis. 2013;1:27–8. [Google Scholar]
14. Assadi F. Psychological impact of chronic kidney disease among children and adolescents: Not rare and not benign. J Nephropathol. 2013;2:1–3. [PMC free article] [PubMed] [Google Scholar]
15. Junaid Nazar CM, Kindratt TB, Ahmad SM, Ahmed M, Anderson J. Barriers to the successful practice of chronic kidney diseases at the primary health care level; a systematic review. J Renal Inj Prev. 2014;3:61–7. [PMC free article] [PubMed] [Google Scholar]
16. Motamedi P, Dehghani N, Kiani F, Taheri Z, Torkamaneh S, Nasri H. New concepts in diabetic kidney disease. J Nephropharmacol. 2015;4:47–8. [PMC free article] [PubMed] [Google Scholar]
17. Nasri H. The awareness of chronic kidney disease and aging; the focus of world kidney day in 2014. J Nephropharmacol. 2014;3:1–2. [PMC free article] [PubMed] [Google Scholar]
18. Hernandez GT, Nasri H. World Kidney Day 2014: Increasing awareness of chronic kidney disease and aging. J Renal Inj Prev. 2013;3:3–4. [PMC free article] [PubMed] [Google Scholar]
19. USRDS: The United States Renal Data System. Excerpts from the USRDS 2009 annual data report: Atlas of end- stage renal disease in the United States. Am J Kidney Dis. 2010;55(Suppl 1):S1. [Google Scholar]
20. Ardalan MR, Sanadgol H, Nasri H, Baradaran A, Tamadon MR, Rafieian-Kopaei R. Vitamin D therapy in diabetic kidney disease; current knowledge on a public health problem. J Parathyr Dis. 2014;2:15–7. [Google Scholar]
21. Sechi LA, Catena C, Zingaro L, Melis A, De Marchi S. Abnormalities of glucose metabolism in patients with early renal failure. Diabetes. 2002;51:1226–32. [PubMed] [Google Scholar]
22. Einollahi B, Motalebi M, Salesi M, Ebrahimi M, Taghipour M. The impact of cytomegalovirus infection on new-onset diabetes mellitus after kidney transplantation: A review on current findings. J Nephropathol. 2014;3:139–48. [PMC free article] [PubMed] [Google Scholar]
23. Hajivandi A, Amiri M. World diabetes day 2013: Diabetes mellitus and nephrology. J Nephropharmacol. 2013;2:31–2. [PMC free article] [PubMed] [Google Scholar]
24. Rafieian-Kopaie M, Nasri H. Silymarin and diabetic nephropathy. J Renal Inj Prev. 2012;1:3–5. [PMC free article] [PubMed] [Google Scholar]
25. Tolouian R, T Hernandez G. Prediction of diabetic nephropathy: The need for a sweet biomarker. J Nephropathol. 2013;2:4–5. [PMC free article] [PubMed] [Google Scholar]
26. Baradaran A, Mardani S, Tamadon MR, Shahbazian H, Beladi Mousavi SS. Sevelamer, a phosphate-binding resin with beneficial effect in diabetic kidney disease; a modern paradigm shift. J Parathyr Dis. 2014;2:61–2. [Google Scholar]
27. Andrianesis V, Doupis J. The role of kidney in glucose homeostasis--SGLT2 inhibitors, a new approach in diabetes treatment. Expert Rev Clin Pharmacol. 2013;6:519–39. [PubMed] [Google Scholar]
28. Nasri H. Consequences of hypomagnesemia in type 2 diabetes mellitus patients. J Renal Inj Prev. 2014;3:99–100. [PMC free article] [PubMed] [Google Scholar]
29. Shahbazian H, Rezaii I. Diabetic kidney disease; review of the current knowledge. J Renal Inj Prev. 2013;2:73–80. [PMC free article] [PubMed] [Google Scholar]
30. Nasri H. Comment on: Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients. J Renal Inj Prev. 2012;1:13–4. [PMC free article] [PubMed] [Google Scholar]
31. Baradaran A. Lipoprotein (a), type 2 diabetes and nephropathy; the mystery continues. J Nephropathol. 2012;1:126–9. [PMC free article] [PubMed] [Google Scholar]
32. Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC. Insulin resistance in patients with chronic kidney disease. J Biomed Biotechnol 2012. 2012:691369. [PMC free article] [PubMed] [Google Scholar]
33. Behradmanesh S, Nasri P. Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients. J Renal Inj Prev. 2012;1:23–6. [PMC free article] [PubMed] [Google Scholar]
34. Chang E, Donkin SS, Teegarden D. Parathyroid hormone suppresses insulin signaling in adipocytes. Mol Cell Endocrinol. 2009;307:77–82. [PMC free article] [PubMed] [Google Scholar]
35. Rafieian-Kopaei M, Hosseini M, Shirzad H. Comment on: Effect of pomegranate flower extract oncis platin-induced nephrotoxicity in rats. J Nephropathol. 2014;3:121–3. [PMC free article] [PubMed] [Google Scholar]
36. Onuigbo MA, Agbasi N. Intraoperative hypotension — a neglected causative factor in hospital-acquired acute kidney injury; a Mayo Clinic Health System experience revisited. J Renal Inj Prev. 2015;4:61–7. [PMC free article] [PubMed] [Google Scholar]
37. Karimi A, Moradi MT. Total phenolic compounds and in vitro antioxidant potential of crude methanol extract and the correspond fractions of Quercus brantii L. acorn. J HerbMed Pharmacol. 2015;4:35–9. [Google Scholar]
38. Nasri H, Shirzad H. Toxicity and safety of medicinal plants. J HerbMed Pharmacol. 2013;2:21–2. [Google Scholar]
39. Azadegan-Dehkordi F, Bagheri N, Shirzad H, Rafieian-Kopaei M. The role of Th1 and Th17 cells in glomerulonephritis. J Nephropathol. 2015;4:32–7. [PMC free article] [PubMed] [Google Scholar]
40. Rafieian-Kopaei M. Medicinal plants and the human needs. J HerbMed Pharmacol. 2012;1:1–2. [Google Scholar]
41. Ahmadi-Renani S, Fasihi-Ramandi M, Ahmadi K. Ganoderma lucidum: A promising anti-inflammatory medicinal plant. J HerbMed Pharmacol. 2014;3:67–8. [Google Scholar]
42. Nasri H, Behradmanesh S, Ahmadi A, Baradaran A, Nasri P, Rafieian-Kopaei M. Association of serum lipids with level of blood pressure in type 2 diabetic patients. J Renal Inj Prev. 2013;3:43–6. [PMC free article] [PubMed] [Google Scholar]
43. Rafieian-Kopaei M, Nasri H. Vitamin D therapy in diabetic kidney disease. J Nephropharmacol. 2014;3:3–4. [PMC free article] [PubMed] [Google Scholar]
44. Mirhoseini M, Baradaran A, Rafieian-Kopaei M. Medicinal plants, diabetes mellitus and urgent needs. J HerbMed Pharmacol. 2013;2:53–4. [Google Scholar]
45. Nasri H, Behradmanesh S, Ahmadi A, Rafieian-Kopaei M. Impact of oral vitamin D (cholecalciferol) replacement therapy on blood pressure in type 2 diabetes patients; a randomized, double-blind, placebo controlled clinical trial. J Nephropathol. 2014;3:29–33. [PMC free article] [PubMed] [Google Scholar]
46. Behradmanesh S, Derees F, Rafieian-Kopaei M. Effect of Salvia officinalis on diabetic patients. J Renal Inj Prev. 2013;2:51–4. [PMC free article] [PubMed] [Google Scholar]
47. Beladi-Mousavi SS, Bashardoust B, Nasri H, Ahmadi A, Tolou-Ghamari Z, Hajian S. Serum uric acid level and its association with cardio-metabolic risk factors in prediabetics. J Parathyr Dis. 2014;2:51–2. [Google Scholar]
48. Sadeghi M, Khosravi-Boroujeni H, Sarrafzadegan N, Asgary S, Roohafza H, Gharipour M, et al. Cheese consumption in relation to cardiovascular risk factors among Iranian adults- IHHP Study. Nutr Res Pract. 2014;8:336–41. [PMC free article] [PubMed] [Google Scholar]
49. Nasri H, Ardalan MR, Rafieian-Kopaei R. On the occasion of world hypertension day 2014. J Parathyr Dis. 2014;2:19–20. [Google Scholar]
50. Said S, Hernandez GT. The link between chronic kidney disease and cardiovascular disease. J Nephropathol. 2014;3:99–104. [PMC free article] [PubMed] [Google Scholar]
51. Nasri H, Behradmanesh S, Maghsoudi AR, Ahmadi A, Nasri P, Rafieian-Kopaei M. Efficacy of supplementary vitamin D on improvement of glycemic parameters in patients with type 2 diabetes mellitus; a randomized double blind clinical trial. J Renal Inj Prev. 2013;3:31–4. [PMC free article] [PubMed] [Google Scholar]
52. Rafieian-kopaei M, Keshvari M, Asgary S, Salimi M, Heidarian E. Potential role of a nutraceutical spice (Allium hirtifolium) in reduction of atherosclerotic plaques. J HerbMed Pharmacol. 2013;2:23–8. [Google Scholar]
53. Ghasemi-Pirbaluti M, Pourgheysari B, Shirzad H, Motaghi E, Askarian Dehkordi N, Surani Z, et al. Effect of Epigallocatechin-3-gallate (EGCG) on cell proliferation inhibition and apoptosis induction in lymphoblastic leukemia cell line. J HerbMed Pharmacol. 2015;4:65–8. [Google Scholar]
54. Shirzad H, Shahrani M, Rafieian-Kopaei M. Comparison of morphine and tramadol effects on phagocytic activity of mice peritoneal phagocytes in vivo. Int Immunopharmacol. 2009;9:968–70. [PubMed] [Google Scholar]
55. Aghaei M, Ghanadian M, Faez F, Esfandiary E. Cytotoxic activities of Euphorbia kopetdaghi against OVCAR-3 and EJ-138 cell lines. J HerbMed Pharmacol. 2015;4:49–52. [Google Scholar]
56. Rafieian-Kopaei M, Nasri H. Ginger and diabetic nephropathy. J Renal Inj Prev. 2013;2:9–10. [PMC free article] [PubMed] [Google Scholar]
57. Sajjadi SE, Ghanadian M, Haghighi M, Mouhebat L. Cytotoxic effect of Cousinia verbascifolia Bunge against OVCAR-3 and HT-29 cancer cells. J HerbMed Pharmacol. 2015;4:15–9. [Google Scholar]
58. Shirzad H, Kiani M, Shirzad M. Impacts of tomato extract on the mice fibrosarcoma cells. J HerbMed Pharmacol. 2013;2:13–6. [Google Scholar]
59. Shirzad H, Taji F, Rafieian-Kopaei M. Correlation between antioxidant activity of garlic extracts and WEHI-164 fibrosarcoma tumor growth in BALB/c mice. J Med Food. 2011;14:969–74. [PubMed] [Google Scholar]
60. Sarteshnizi NA, Dehkordi MM, Farsani SK, Teimori H. Anticancer activity of ethanolic extract of propolis on AGS cell line. J HerbMed Pharmacol. 2015;4:29–34. [Google Scholar]
61. Sarrafchi A, Bahmani M, Shirzad H, Rafieian-Kopaei M. Oxidative stress and Parkinson's disease: New hopes in treatment with herbal antioxidants. Curr Pharm Des. 2015 Nov 12; Epub ahead of print. [PubMed] [Google Scholar]
62. Baradaran A, Rabiei Z, Rafieian M, Shirzad H. A review study on medicinal plants affecting amnesia through cholinergic system. J HerbMed Pharmacol. 2012;1:3–9. [Google Scholar]
63. Rafieian-Kopaei M, Baradaran A. Combination of metformin with other antioxidants may increase its renoprotective efficacy. J Renal Inj Prev. 2013;2:35–6. [PMC free article] [PubMed] [Google Scholar]
64. Bahmani M, Sarrafchi A, Shirzad H, Rafieian-Kopaei M. Autism: Pathophysiology and promising herbal remedies. Curr Pharm Des. 2015 Nov 12; Epub ahead of print. [PubMed] [Google Scholar]
65. Nasri H, Ahmadi A, Baradaran A, Nasri P, Hajian S, Pour-Arian A, et al. A biochemical study on ameliorative effect of green tea (Camellia sinensis) extract against contrast media induced acute kidney injury. J Renal Inj Prev. 2013;3:47–9. [PMC free article] [PubMed] [Google Scholar]
66. Sotodeh-Asl N, Tamadon MR, Malek F, Zahmatkesh M. Vitamin D deficiency and psychological disorders. J Parathyr Dis. 2014;2:21–5. [Google Scholar]
67. Bahmani M, Rafieian M, Baradaran A, Rafieian S, Rafieian-kopaei M. Nephrotoxicity and hepatotoxicity evaluation of Crocus sativus stigmas in neonates of nursing mice. J Nephropathol. 2014;3:81–5. [PMC free article] [PubMed] [Google Scholar]
68. Nasri H. Renoprotective effects of garlic. J Renal Inj Prev. 2013;2:27–8. [PMC free article] [PubMed] [Google Scholar]
69. Ansari R, Shahinfard N, Namjou A, Rafieian M, Shirzad H, Rafieian-kopaei M. Ameliorative property of Teucrium polium on second degree burn. J HerbMed Pharmacol. 2013;2:9–11. [Google Scholar]
70. Bahmani M, Vakili-Saatloo N, Maghsoudi R, Momtaz H, Saki K, Kazemi-Ghoshchi B, et al. A comparative study on the effect of ethanol extract of wild Scrophularia deserti and streptomycin on Brucellla melitensis. J HerbMed Pharmacol. 2013;2:17–20. [Google Scholar]
71. Modaresi M, Pouriyanzadeh A, Asadi-Samani M. Antiepileptic activity of hydroalcoholic extract of basil in mice. J HerbMed Pharmacol. 2014;3:57–60. [Google Scholar]
72. Bagheri N, Taghikhani A, Rahimian G, Salimzadeh L, Azadegan Dehkordi F, Zandi F, et al. Association between virulence factors of helicobacter pylori and gastric mucosal interleukin-18 mRNA expression in dyspeptic patients. Microb Pathog. 2013;65:7–13. [PubMed] [Google Scholar]
73. Kheirabadi KP, Dehkordi SS, Kheibari P. Effect of Kelussia odoratissima Mozaff essential oil on promastigot form of Leishmania major (in vitro) J HerbMed Pharmacol. 2015;4:10–4. [Google Scholar]
74. Hosseinpour M, Mobini-Dehkordi M, Saffar B, Teimori H. Antiproliferative effects of Matricaria chamomilla on Saccharomyces cerevisiae. J HerbMed Pharmacol. 2013;2:49–51. [Google Scholar]
75. Moghim H, Taghipoor S, Shahinfard N, Kheiri S, Heydari Z, Rafieian S. Antifungal effects of Allium ascalonicum, Marticaria chamomilla and Stachys lavandulifolia extracts on Candida albicans. J HerbMed Pharmacol. 2014;3:9–14. [Google Scholar]
76. Amanpour R, Abbasi-Maleki S, Neyriz-Naghadehi M, Asadi-Samani M. Antibacterial effects of Solanum tuberosum peel ethanol extract in vitro. J HerbMed Pharmacol. 2015;4:45–8. [Google Scholar]
77. Bahmani M, Vakili-Saatloo N, Gholami-Ahangaran M, Karamati SA, Banihabib E, Hajigholizadeh G, et al. A comparison study on the anti-leech effects of onion (Allium cepa L) and ginger (Zingiber officinale) with levamisole and triclabendazole. J HerbMed Pharmacol. 2013;2:1–3. [Google Scholar]
78. Sharafati-chaleshtori R, Rafieian-kopaei M. Screening of antibacterial effect of the Scrophularia Striata against E. coli in vitro. J HerbMed Pharmacol. 2014;3:31–4. [Google Scholar]
79. Jabari M, Asghari G, Ghanadian M, Jafari A, Yousefi H, Jafari R. Effect of Chaerophyllum macropodum extracts on Trichomonas vaginalis in vitro. J HerbMed Pharmacol. 2015;4:61–4. [Google Scholar]
80. Mardani S, Nasri H, Rafieian-Kopaei M, Beladi Mousavi SS. Hyperuricemia; a new look at an old problem. J Nephropharmacol. 2012;1:13–4. [PMC free article] [PubMed] [Google Scholar]
81. Momeni A. Serum uric acid and diabetic nephropathy. J Renal Inj Prev. 2012;1:37–8. [PMC free article] [PubMed] [Google Scholar]
82. Mardani S, Nasri H, Hajian S, Ahmadi A, Kazemi R, Rafieian-Kopaei M. Impact of Momordica charantia extract on kidney function and structure in mice. J Nephropathol. 2014;3:35–40. [PMC free article] [PubMed] [Google Scholar]
83. Rahimi Z. Parathyroid hormone, glucose metabolism and diabetes mellitus. J Parathyr Dis. 2014;2:55–6. [Google Scholar]
84. Rahimi-Madiseh M, Heidarian E, Rafieian-kopaei M. Biochemical components of Berberis lycium fruit and its effects on lipid profile in diabetic rats. J HerbMed Pharmacol. 2014;3:15–9. [Google Scholar]
85. Rahimi Z. ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. J Nephropathol. 2012;1:143–51. [PMC free article] [PubMed] [Google Scholar]
86. Roshan B, Stanton RC. A story of microalbuminuria and diabetic nephropathy. J Nephropathol. 2013;2:234–40. [PMC free article] [PubMed] [Google Scholar]
87. Kalantar Zadeh K. A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death: A1C remains the gold standard outcome predictor in diabetic dialysis patients. Counterpoint. Diabetes Care. 2012;35:1625–8. [PMC free article] [PubMed] [Google Scholar]
88. McMurray SD, Johnson G, Davis S, McDougall K. Diabetes education and care management significantly improve patient outcomes in the dialysis unit. Am J Kidney Dis. 2002;40:566–75. [PubMed] [Google Scholar]
89. Stanton RC. Oxidative stress and diabetic kidney disease. Curr Diab Rep. 2011;11:330–6. [PubMed] [Google Scholar]
90. Ghorbani A, Rafieian-Kopaei M, Nasri H. Lipoprotein (a): More than a bystander in the etiology of hypertension?. A study on essential hypertensive patients not yet on treatment. J Nephropathol. 2013;2:67–70. [PMC free article] [PubMed] [Google Scholar]
91. Ardalan MR, Sanadgol H, Nasri H, Baradaran A, Tamadon MR, Rafieian-Kopaei R. Impact of vitamin D on the immune system in kidney disease. J Parathyr Dis. 2013;1:17–20. [Google Scholar]
92. Ghaderian SB, Beladi-Mousavi SS. The role of diabetes mellitus and hypertension in chronic kidney disease. J Renal Inj Prev. 2014;3:109–10. [PMC free article] [PubMed] [Google Scholar]
93. Rafieian-Kopaei M, Baradaran A. Teucrium polium and kidney. J Renal Inj Prev. 2013;2:3–4. [PMC free article] [PubMed] [Google Scholar]
94. Jafarpoor N, Abbasi-Maleki S, Asadi-Samani M, Khayatnouri MH. Evaluation of antidepressant-like effect of hydroalcoholic extract of Passiflora incarnata in animal models of depression in male mice. J HerbMed Pharmacol. 2014;3:41–5. [Google Scholar]
95. Baradaran A, Nasri H, Nematbakhsh M, Rafieian-Kopaei M. Antioxidant activity and preventive effect of aqueous leaf extract of Aloe Vera on gentamicin-induced nephrotoxicity in male Wistar rats. Clin Ter. 2014;165:7–11. [PubMed] [Google Scholar]
96. Khoshdel A, Famuri F, Keivani E, Lotfizadeh M, Kasiri KA, Rafieian M. The effect of aqueous Elaeagnus angustifolia extract on acute non-inflammatory diarrhea in 1-5 year old children. J HerbMed Pharmacol. 2014;3:53–6. [Google Scholar]
97. Lala MA, Nazar CM, Lala HA, Singh JK. Interrelation between blood pressure and diabetes. J Renal Endocrinol. 2015;1:e05. [Google Scholar]
98. Baharara J, Balanejad SZ, Kamareh E, Asadi-Samani M. The effects of green tea extract on teratogenicity induced by low frequency electromagnetic field on bone marrow Balb/C mice embryo. J HerbMed Pharmacol. 2014;3:47–51. [Google Scholar]
99. Rafieian-Kopaei M. Medicinal plants for renal injury prevention. J Renal Inj Prev. 2013;2:63–5. [PMC free article] [PubMed] [Google Scholar]
100. Ardalan MR, Rafieian-Kopaei M. Antioxidant supplementation in hypertension. J Renal Inj Prev. 2013;3:39–40. [PMC free article] [PubMed] [Google Scholar]
101. Ardalan MR, Rafieian-Kopaei M. Is the safety of herbal medicines for kidneys under question? J Nephropharmacol. 2013;2:11–2. [PMC free article] [PubMed] [Google Scholar]
102. Kooti W, Moradi M, Akbari SA, Sharafi-Ahvazi N, Asadi-Samani M, Ashtary-Larky D. Therapeutic and pharmacological potential of Foeniculum vulgare Mill: A review. J HerbMed Pharmacol. 2015;4:1–9. [Google Scholar]
103. Nasri H, Rafieian-kopaei M, Shirzad M, Rafieian M, Sahinfard Rafieian S. Effects of Allium sativum on liver enzymes and atherosclerotic risk factors. J HerbMed Pharmacol. 2013;2:23–8. [Google Scholar]
104. Aboutari J, Haydarnejad MS, Fatahian Dehkordi R, Vanani SR. Histomorphometric study on the effects of Artemisia sieberi extract in mice skin. J HerbMed Pharmacol. 2015;4:20–4. [Google Scholar]
105. Sewell RD, Rafieian-Kopaei M. The history and ups and downs of herbal medicine usage. J HerbMed Pharmacol. 2014;3:1–3. [Google Scholar]
106. Tavafi M. Suggestions for attenuation of renal ischemia reperfusion injury based on mechanisms involved in epithelial cells damages. J Nephropharmacol. 2015;4:1–3. [PMC free article] [PubMed] [Google Scholar]
107. Ardalan MR, Nasri H. Acute kidney injury; the focus of world kidney day in 2013. J Nephropharmacol. 2013;2:15–6. [PMC free article] [PubMed] [Google Scholar]
108. Hajivandi A, Amiri M. World Kidney Day 2014: Kidney disease and elderly. J Parathyr Dis. 2014;2:3–4. [Google Scholar]
109. Baradaran A, Rafieian-Kopaei M. Histopathological study of the combination of metformin and garlic juice for the attenuation of gentamicin renal toxicity in rats. J Renal Inj Prev. 2013;2:15–21. [PMC free article] [PubMed] [Google Scholar]
110. Tavafi M. Complexity of diabetic nephropathy pathogenesis and design of investigations. J Renal Inj Prev. 2013;2:59–62. [PMC free article] [PubMed] [Google Scholar]
111. Tavafi M. Diabetic nephropathy and antioxidants. J Nephropathol. 2013;2:20–7. [PMC free article] [PubMed] [Google Scholar]
112. Tamadon MR, Baradaran A, Rafieian-Kopaei M. Antioxidant and kidney protection; differential impacts of single and whole natural antioxidants. J Renal Inj Prev. 2013;3:41–2. [PMC free article] [PubMed] [Google Scholar]
113. Nasri H, Rafieian-Kopaei M. Herbal medicine and diabetic kidney disease. J Nephropharmacol. 2013;2:1–2. [PMC free article] [PubMed] [Google Scholar]
114. Rafieian-Kopaei M, Baradaran A, Rafieian M. Plants antioxidants: From laboratory to clinic. J Nephropathol. 2013;2:152–3. [PMC free article] [PubMed] [Google Scholar]
115. Khajehdehi P. Turmeric: Reemerging of a neglected Asian traditional remedy. J Nephropathol. 2012;1:17–22. [PMC free article] [PubMed] [Google Scholar]
116. Rafieian-Kopaei M, Motamedi P, Vakili L, Dehghani N, Kiani F, Taheri Z, et al. Green tea and type 2 diabetes mellitus. J Nephropharmacol. 2014;3:21–3. [PMC free article] [PubMed] [Google Scholar]
117. Spasovski D. Renal markers for assessment of renal tubular and glomerular dysfunction. J Nephropharmacol. 2013;2:23–5. [PMC free article] [PubMed] [Google Scholar]
118. Soleimani AR, Akbari H, Soleimani S, Beladi Mousavi SS, Tamadon MR. Effect of sour tea (Lipicom) pill versus captopril on the treatment of hypertension. J Renal Inj Prev. 2015;4:73–9. [PMC free article] [PubMed] [Google Scholar]
119. Rafieian-Kopaei M. Natural sources of vitamin D. J Parathyr Dis. 2015;3:10–1. [Google Scholar]
120. Hajian S. Renoprotective effects of green tea. J Nephropharmacol. 2013;2:21–2. [PMC free article] [PubMed] [Google Scholar]
121. Ardalan MR, Ghafari A, Hamzavi F, Nasri H, Baradaran B, Majidi J, et al. Antiphospholipase A2 receptor antibody in idiopathic membranous nephropathy: A report from Iranian population. J Nephropathol. 2013;2:241–8. [PMC free article] [PubMed] [Google Scholar]
122. Atkins RC, Zimmet P. 2010 International Society of Nephrology/International Federation of Kidney Foundations World Kidney Day Steering Committee and the International Diabetes Federation. Diabetic kidney disease: Act now or pay later. Am J Med Sci. 2010;339:102–4. [PubMed] [Google Scholar]
123. Turgut F, Bolton WK. Potential new therapeutic agents for diabetic kidney disease. Am J Kidney Dis. 2010;55:928–40. [PubMed] [Google Scholar]
124. Oomichi T, Emoto M, Tabata T, Morioka T, Tsujimoto Y, Tahara H, et al. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: A 7-year observational study. Diabetes Care. 2006;29:1496–500. [PubMed] [Google Scholar]
125. Shurraw S, Majumdar SR, Thadhani R, Wiebe N, Tonelli M. Alberta Kidney Disease Network. Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis. Am J Kidney Dis. 2010;55:875–84. [PubMed] [Google Scholar]
126. Williams ME, Lacson E, Jr, Wang W, Lazarus JM, Hakim R. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: Comparative results of traditional and time-dependent Cox model analyses. Clin J Am Soc Nephrol. 2010;5:1595–601. [PMC free article] [PubMed] [Google Scholar]
127. Behradmanesh S, Nasri H. Association of serum calcium with level of blood pressure in type 2 diabetic patients. J Nephropathol. 2013;2:254–7. [PMC free article] [PubMed] [Google Scholar]
128. Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK. New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis. Am J Kidney Dis. 2007;49:524–32. [PubMed] [Google Scholar]
129. Nasri H. On the occasion of the world diabetes day 2013; diabetes education and prevention; a nephrology point of view. J Renal Inj Prev. 2013;2:31–2. [PMC free article] [PubMed] [Google Scholar]
130. Harrigan RA, Nathan MS, Beattie P. Oral agents for the treatment of type 2 diabetes mellitus: Pharmacology, toxicity, and treatment. Ann Emerg Med. 2001;38:68–78. [PubMed] [Google Scholar]
131. Gribble FM, Reimann F. Differential selectivity of insulin secretagogues: Mechanisms, clinical implications, and drug interactions. J Diabetes Complications. 2003;17(Suppl):11–5. [PubMed] [Google Scholar]
132. Lubowsky ND, Siegel R, Pittas AG. Management of glycemia in patients with diabetes mellitus and CKD. Am J Kidney Dis. 2007;50:865–79. [PubMed] [Google Scholar]
133. Matzke GR, Aronoff GR, Atkinson AJ, Jr, Bennett WM, Decker BS, Eckardt KU, et al. Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int. 2011;80:1122–37. [PubMed] [Google Scholar]
134. Snyder RW, Berns JS. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dial. 2004;17:365–70. [PubMed] [Google Scholar]
135. Proks P, Reimann F, Green N, Gribble F, Ashcroft F. Sulfonylurea stimulation of insulin secretion. Diabetes. 2002;51(Suppl 3):S368–76. [PubMed] [Google Scholar]
136. Krentz AJ, Bailey CJ. Oral antidiabetic agents: Current role in type 2 diabetes mellitus. Drugs. 2005;65:385–411. [PubMed] [Google Scholar]
137. Fryer LG, Parbu-Patel A, Carling D. The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem. 2002;277:25226–32. [PubMed] [Google Scholar]
138. Beladi Mousavi SS, Nasri H, Rafieian-Kopaei M, Tamadon MR. Metformin improves diabetic kidney disease. J Nephropharmacol. 2012;1:1–2. [PMC free article] [PubMed] [Google Scholar]
139. Bodmer M, Meier C, Krähenbühl S, Jick SS, Meier CR. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: A nested case-control analysis. Diabetes Care. 2008;31:2086–91. [PMC free article] [PubMed] [Google Scholar]
140. Duong JK, Furlong TJ, Roberts DM, Graham GG, Greenfield JR, Williams KM, et al. The role of metformin in metformin-Associated Lactic Acidosis (MALA): Case series and formulation of a model of pathogenesis. Drug Saf. 2013 Epub ahead of print. [PubMed] [Google Scholar]
141. Ramirez SP, Albert JM, Blayney MJ, Tentori F, Goodkin DA, Wolfe RA, et al. Rosiglitazone is associated with mortality in chronic hemodialysis patients. J Am Soc Nephrol. 2009;20:1094–101. [PMC free article] [PubMed] [Google Scholar]
142. Inoue T, Shibahara N, Miyagawa K, Itahana R, Izumi M, Nakanishi T, et al. Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure. Clin Nephrol. 2003;60:90–5. [PubMed] [Google Scholar]
143. Nagai T, Imamura M, Iizuka K, Mori M. Hypoglycemia due to nateglinide administration in diabetic patient with chronic renal failure. Diabetes Res Clin Pract. 2003;59:191–4. [PubMed] [Google Scholar]
144. Hasslacher C. Multinational Repaglinide Renal Study Group. Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function. Diabetes Care. 2003;26:886–91. [PubMed] [Google Scholar]
145. Nasri H, Ahmadi A, Baradaran A, Momeni A, Nasri P, Mardani S, et al. Clinicopathological correlations in lupus nephritis; a single center experience. J Nephropathol. 2014;3:115–20. [PMC free article] [PubMed] [Google Scholar]
146. Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2008 CD006297. [PMC free article] [PubMed] [Google Scholar]
147. Mardani S, Nasri H. Catastrophic antiphospholipid syndrome presenting with sudden renal failure and past history of long-lasting psychosis and hypertension in a 42 years woman. J Nephropathol. 2013;2:110–3. [PMC free article] [PubMed] [Google Scholar]
148. Nasri H, Ahmadi A, Rafieian-Kopaei M, Bashardoust B, Nasri P, Mubarak M. Association of glomerular C4d deposition with various demographic data in IgA nephropathy patients; a preliminary study. J Nephropathol. 2015;4:19–23. [PMC free article] [PubMed] [Google Scholar]
149. Momeni A, Nasri H. Concurrent diabetic nephropathy and C1q nephropathy in a young male patient: The first report in literature. J Nephropathol. 2013;2:201–3. [PMC free article] [PubMed] [Google Scholar]
150. Kudva YC, Basu A, Jenkins GD, Pons GM, Quandt LL, Gebel JA, et al. Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes. Diabetes Care. 2005;28:10–4. [PubMed] [Google Scholar]
151. Khodadadi S. Role of herbal medicine in boosting immune system. Immunopathol Persa. 2015;1:e01. [Google Scholar]
152. Mubarak M, Nasri H. What nephrolopathologists need to know about antiphospholipid syndrome-associated nephropathy: Is it time for formulating a classification for renal morphologic lesions? J Nephropathol. 2014;3:4–8. [PMC free article] [PubMed] [Google Scholar]
153. Kafeshani M. Ginger, micro-inflammation and kidney disease. J Renal Endocrinol. 2015;1:e04. [Google Scholar]
154. Hajian SH. Positive effect of antioxidants on immune system. Immunopathol Persa. 2015;1:e02. [Google Scholar]
155. Nasri H. Deposition of complement in the vessels of immunoglobulin A nephropathy patients. Immunopathol Persa. 2015;1:e03. [Google Scholar]
156. Ahmadi A, Soori H. Important statistical points to improve and promote the methodology of the articles on medical sciences, particularly nephrology and kidney; a review article. J Renal Inj Prev. 2015;4:4–8. [PMC free article] [PubMed] [Google Scholar]
157. Nasri H, Mubarak M. Extracapillary proliferation in IgA nephropathy; recent findings and new ideas. J Nephropathol. 2015;4:1–5. [PMC free article] [PubMed] [Google Scholar]
158. Bah AO, Lamine C, Balde MC, Bah ML, Rostaing L. Epidemiology of chronic kidney diseases in the Republic of Guinea; future dialysis needs. J Nephropathol. 2015;4:127–33. [PMC free article] [PubMed] [Google Scholar]
159. Rafieian-Kopaei M, Baradaran A. On the occasion of world diabetes day 2105; act today to change tomorrow. J Renal Endocrinol. 2015;1:e02. [Google Scholar]
160. Nasri H. Hypertension and renal failure with right arm pulse weakness in a 65 years old man. J Nephropathol. 2012;1:130–3. [PMC free article] [PubMed] [Google Scholar]
161. Nouri P, Nasri H. Irisin and kidney disease; new concepts. J Renal Endocrinol. 2015;1:e03. [Google Scholar]